Skip to main content
. 2020 Jan 7;19(3):1673–1680. doi: 10.3892/etm.2020.8425

Figure 3.

Figure 3.

Expression of miR-222 in tissues and peripheral blood. (A) Expression of miR-222 in tumor-adjacent and tumor tissues from cervical cancer patients as determined by RT-qPCR. Paired Student's t-test was used for comparison between the two groups. **P<0.01 compared with tumor-adjacent tissues. (B) Expression of miR-222 in peripheral blood from control and cervical cancer patients as determined by RT-qPCR. Unpaired Student's t-test was used for comparison between the two groups. *P<0.05 compared with control. Control, healthy subjects; miR-222, microRNA-222; RT-qPCR, reverse transcription quantitative polymerase chain reaction.